Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • The following terms were not found in PubMed: review literature[mh], consumerj[sb].
  • See the search details.

Results: 1 to 20 of 175

1.

Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy.

Segarane B, Li A, Paudel R, Scholz S, Neumann J, Lees A, Revesz T, Hardy J, Mathias CJ, Wood NW, Holton J, Houlden H.

Neurology. 2009 Mar 31;72(13):1185-6. Review. No abstract available. PMID: 19332698 [PubMed - indexed for MEDLINE]Related articles

2.

Proposed neuroimaging criteria for the diagnosis of multiple system atrophy.

Brooks DJ, Seppi K; Neuroimaging Working Group on MSA.

Mov Disord. 2009 May 15;24(7):949-64. Review.PMID: 19306362 [PubMed - indexed for MEDLINE]Related articles

3.

Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy.

Petzold A, Thompson EJ, Keir G, Quinn N, Holmberg B, Dizdar N, Wenning GK, Rascol O, Tolosa E, Rosengren L.

J Neurol Sci. 2009 Apr 15;279(1-2):76-9. Epub 2009 Feb 4.PMID: 19195665 [PubMed - indexed for MEDLINE]Related articles

4.

Serum cholesterol levels and the risk of multiple system atrophy: a case-control study.

Lee PH, Lim TS, Shin HW, Yong SW, Nam HS, Sohn YH.

Mov Disord. 2009 Apr 15;24(5):752-8.PMID: 19185013 [PubMed - indexed for MEDLINE]Related articles

5.

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN; NNIPPS Study Group.

Brain. 2009 Jan;132(Pt 1):156-71. Epub 2008 Nov 23.PMID: 19029129 [PubMed - indexed for MEDLINE]Related articlesFree article

6.

Multiple system atrophy: a primary oligodendrogliopathy.

Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG.

Ann Neurol. 2008 Sep;64(3):239-46. Review.PMID: 18825660 [PubMed - indexed for MEDLINE]Related articles

7.

Multiple system atrophy.

Bhidayasiri R, Ling H.

Neurologist. 2008 Jul;14(4):224-37. Review.PMID: 18617848 [PubMed - indexed for MEDLINE]Related articles

8.

The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy.

Heo JH, Lee ST, Chu K, Kim M.

J Neurol Sci. 2008 Aug 15;271(1-2):87-90. Epub 2008 May 7.PMID: 18466925 [PubMed - indexed for MEDLINE]Related articles

9.

Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure.

Gamboa A, Shibao C, Diedrich A, Paranjape SY, Farley G, Christman B, Raj SR, Robertson D, Biaggioni I.

Hypertension. 2008 Jun;51(6):1531-6. Epub 2008 Apr 21.PMID: 18426998 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

Multiple system atrophy: pathophysiology, treatment and nursing care.

Hardy J.

Nurs Stand. 2008 Feb 6-12;22(22):50-6; quiz 58. Review.PMID: 18333558 [PubMed - indexed for MEDLINE]Related articles

11.

Dysautonomia and cognitive dysfunction in Parkinson's disease.

Poewe W.

Mov Disord. 2007 Sep;22 Suppl 17:S374-8. Review.PMID: 18175399 [PubMed - indexed for MEDLINE]Related articles

12.

Multiple system atrophy: alpha-synuclein and neuronal degeneration.

Yoshida M.

Neuropathology. 2007 Oct;27(5):484-93. Review.PMID: 18018485 [PubMed - indexed for MEDLINE]Related articles

13.

Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy.

Trojanowski JQ, Revesz T; Neuropathology Working Group on MSA.

Neuropathol Appl Neurobiol. 2007 Dec;33(6):615-20.PMID: 17990994 [PubMed - indexed for MEDLINE]Related articles

14.

Potential outcome measures and trial design issues for multiple system atrophy.

May S, Gilman S, Sowell BB, Thomas RG, Stern MB, Colcher A, Tanner CM, Huang N, Novak P, Reich SG, Jankovic J, Ondo WG, Low PA, Sandroni P, Lipp A, Marshall FJ, Wooten F, Shults CW; North American Multiple System Atrophy Study Group.

Mov Disord. 2007 Dec;22(16):2371-7.PMID: 17914727 [PubMed - indexed for MEDLINE]Related articles

15.

Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy.

Lee PH, Kim JW, Bang OY, Ahn YH, Joo IS, Huh K.

Clin Pharmacol Ther. 2008 May;83(5):723-30. Epub 2007 Sep 26.PMID: 17898702 [PubMed - indexed for MEDLINE]Related articles

16.

Progress on pontocerebellar hypoplasia.

Hevner RF.

Acta Neuropathol. 2007 Oct;114(4):401-2. Epub 2007 Aug 21. Review. No abstract available. PMID: 17710422 [PubMed - indexed for MEDLINE]Related articles

17.

Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: impact on determining phenotype spectrum.

Ozawa T.

Acta Neuropathol. 2007 Sep;114(3):201-11. Epub 2007 Jun 26. Review.PMID: 17593377 [PubMed - indexed for MEDLINE]Related articles

18.

Urinary and erectile dysfunction in multiple system atrophy (MSA).

Papatsoris AG, Papapetropoulos S, Singer C, Deliveliotis C.

Neurourol Urodyn. 2008;27(1):22-7. Review.PMID: 17563111 [PubMed - indexed for MEDLINE]Related articles

19.

Paradoxical vocal cord motion: a review focused on multiple system atrophy.

Shiba K, Isono S, Nakazawa K.

Auris Nasus Larynx. 2007 Dec;34(4):443-52. Epub 2007 May 4. Review.PMID: 17482397 [PubMed - indexed for MEDLINE]Related articles

20.

Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study.

Holmberg B, Johansson JO, Poewe W, Wenning G, Quinn NP, Mathias C, Tolosa E, Cardozo A, Dizdar N, Rascol O, Slaoui T; Growth-Hormone MSA Study Group; European MSA Study Group.

Mov Disord. 2007 Jun 15;22(8):1138-44.PMID: 17469198 [PubMed - indexed for MEDLINE]Related articles

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Find related data

Search details

» See more...